NCT04352777
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Tumor, +6 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
Clinical trial condition
Hormone Receptor Positive Tumor
Explore clinical trials studying Hormone Receptor Positive Tumor. Study availability and eligibility vary by location and protocol.
24 public trials
9 recruiting studies
Hormone Receptor Positive Tumor trial results
NCT05759949
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +11 more
- Locations
-
- Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
- Community Cancer Center North Indianapolis, Indiana, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Completed
Role of Individualized Intervention(s) in Hormone-Receptor Positive Early-stage Breast Cancer
NCT03407768
- Conditions
- Behavior, Breast Cancer, Breast Diseases, +10 more
- Locations
-
- Allan Blair Cancer Center Regina, Saskatchewan, Canada
- Saskatoon Cancer Center Saskatoon, Saskatchewan, Canada
NCT03409198
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Institut Jules Bordet Brussels, Brussels Capital, Belgium
- Cliniques universitaires Saint-Luc Brussels, Brussels Capital, Belgium
- CHU UCL Namur Namur, Belgium
- Soerlandet Hospital HF Kristiansand Kristiansand, Norway
NCT04134884
- Conditions
- Breast Diseases, Breast Neoplasms, Hormone Receptor Positive Tumor, +7 more
- Locations
-
- Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States
- Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States
Completed
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
NCT03809988
- Conditions
- Advanced Breast Cancer, Breast Cancer, Breast Diseases, +7 more
- Locations
-
- Hôpital Jean Minjoz Besançon, France
- Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Centre Georges François Leclerc Dijon, France
- CHD Vendee La Roche-sur-Yon, France
NCT02894398
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- Research Site Aachen, Germany
- Research Site Aschaffenburg, Germany
- Augsburg, Germany
- Research Site Baden-Baden, Germany
NCT03462251
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Gemeinschaftspraxis für Hämatologie und Onkologie Ravensburg, Baden-Wurttemberg, Germany
- Uniklinik RWTH Aachen, Gynäkologie und Geburtsmedizin Aachen, Germany
- Klinikum Mittelbaden Baden-Baden Balg Baden-Baden, Germany
- Gynäkologisches Zentrum Bonn Bonn, Germany
Completed
Dose EScalation Induction of EvERolimus
NCT02387099
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Sana Klinikum Offenbach / German Breast Group Neu-Isenburg, Hesse, Germany
- TU Dresden Dresden, Saxony, Germany
- Bielefeld, Germany
- Cologne, Germany
NCT02441946
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Comprehensive Blood and Cancer Center Bakersfield, California, United States
- University of California-San Diego La Jolla, California, United States
- SMO TRIO -Translational Research Los Angeles, California, United States
- UCLA Medical Center Los Angeles, California, United States